Thomas Fox (JD Supra China)

37 results for Thomas Fox (JD Supra China)

  • Corruption in China: Part 2 – The Bribery Schemes

    After a sidetrack into the ethical train wreck detailed by the SEC Cease and Desist Order re: KPMG yesterday, I am returning to the blog post series I am running based upon the New York Times (NYT) reporting by Alexandra Stevenson and Sui-Lee Wee...

  • Just Who Are You Doing Business With In China?

    How important is due diligence on those with whom you are doing business? Why does it matter if a company is owned or controlled by a foreign government or a political party member of a foreign government?

  • More FCPA Grief Involving Gifts, Travel & Entertainment: PTC in China – Part II

    Yesterday I began a (now) three-part series on the Foreign Corrupt Practices Act (FCPA) enforcement actions involving PTC Inc. (PTC), Parametric Technology (Shanghai) Software Co. Ltd. and Parametric Technology (Hong Kong) Limited. PTC was previously known as Parametric Technology Corporation, and the two other companies were wholly owned subsidiaries (collectively PTC-China).

  • Critiquing FCPA Enforcement and the GSK Domestic Corruption Conviction

    Recently the FCPA Professor posted a blog, entitled “Look in the Mirror Moments”, in which he used written commentary by the US Secretary of the Treasury to the Chinese government about the Chinese governments anti-trust investigations as a mechanism to explore critiques of Foreign Corrupt Practices Act (FCPA) enforcement.

  • West Side Story and GSK In China – Board Oversight and Tone in the Middle

    Yesterday, I celebrated the anniversary of one of America’s cultural lows. But today, I am extremely pleased to open with exactly the opposite, that being one of America’s greatest gifts to the performing arts.

  • Come On Get Happy – The Partridge Family and GSK’s Internal Investigation

    Today we celebrate an anniversary of one of the all-time lows in the American cultural milieu; for on this date in 1970, the television show The Partridge Family appeared on the ABC Television network.

  • Lessons from GSK in China – Internal Controls, Auditing and Monitoring

    One of the questions that GSK will have to face during the next few years of bribery and corruption investigations is how an allegedly massive bribery and corruption scheme occurred in its Chinese operations? The numbers went upwards of $500MM, which coincidentally was the amount of the fine levied by the Chinese court on GSK.

  • Billy the Kid Begins and the GSK China Verdict

    According to This Day in History, 139 years ago today, Billy the Kid was arrested for the first time, for theft. Billy the Kid was believed to have been born in New York City and was later taken out west by his mother.

  • GSK Convicted – We are really, really sorry we paid bribes (and got caught)

    “GSK plc sincerely apologies to the Chinese patients, doctors and hospitals, and the Chinese Government and the Chinese people.” With those words, the British pharmaceutical giant GlaxoSmithKline (GSK) PLC was convicted in a secret trial in a court in the Hunan province of China for bribery and corruption related to its Chinese business unit.

  • Bad News Barnes and China’s Overseas Efforts to Fight Corruption

    I thought about Bad News Barnes whilst reading some recent Financial Times (FT) articles about China’s fight against corruption. They were “China takes its anti-corruption battle to foreign shores” and “China bribe cases pose test for west as suspects flee” both by Jamil Anderlini. I thought they posed some interesting questions for anti-compliance practitioners, law enforcement officials who...

  • Management of Corruption Risks – Business Lessons from GSK

    The Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have made it abundantly clear over the past several years that companies should assess their risk and then manage their own risks.

  • Extraordinary Rendition and Ripples From the Chinese Corruption Investigations

    As many of you know, I am a recovering trial lawyer. So I was very interested when I received a book for review by Paul Batista, entitled Extraordinary Rendition. Not only is Batista a practicing trial lawyer specializing in federal criminal defense...

  • What Can You Do When Risk Changes in a Third Party Relationship?

    The GlaxoSmithKline PLC (GSK) corruption matter in China continues to reverberate throughout the international business community, inside and outside China. The more I think about the related trial of Peter Humphrey and his wife, Yu Yingzeng for violating China’s privacy laws regarding their investigation of who filmed the head of GSK’s China unit head in flagrante delicto with his Chinese...

  • Where to Now St. Peter? – Due Diligence Going Forward in China

    Whatever you might think of where his career went, Elton John had some great early stuff. I still rank Tumbleweed Connection right up there as one of my favorite albums of all-time. And while it was packed with some great tracks, one of my most favorite was Where to Now St. Peter? It was the opening track on Side 2 and dealt with whether a dying soldier would end up in heaven or hell. While...

  • Nixon Announces Resignation; GSK Just Resigns

    Next week, Shanghai’s No. 1 Intermediate People’s Court is scheduled to open a trial against Peter William Humphrey, a 58-year-old British national, and his wife, Yu Yingzeng, a 61-year-old American, on charges of illegally purchasing personal information about Chinese nationals.

  • Looking Back on Johnny Winter and GSK’s 2001 China Bribery Scandal

    Interestingly, there was an article in the Financial Times (FT) by Demetri Sevastopulo and Andrew Ward, entitled “GSK admits to 2001 Chinese bribery scandal”, which reported that the UK pharmaceutical company GlaxoSmithKline PLC (GSK) had been involved in a prior bribery scandal in China back in 2001. They reported,

  • No Sex Please, We’re British: More from GSK in China

    The above is the title of a British television show/play/movie which is a farcical romp about a newlywed couple who mistakenly receive an initial shipment of pornographic pictures, then movies and women, all sent from Sweden to England. The plot turns on their attempts to dispose of the ‘offending materials’...

  • Coolness in Being the Bad Guy? Eli Wallach and GSK

    Eli Wallach died Tuesday. For my money, he was about the coolest bad guy out there. Not tough like Lee Marvin, just cool. My favorite Wallach roles were as Calvera in The Magnificent Seven and as Tuco in The Good, The Bad and The Ugly.

  • The China Market – Changing Times for Foreigners

    China has long been a highly complex market. Fraught with a myriad of business risks, foreign companies consider potential access to China’s 1.3 billion consumers as too enticing to ignore. For many multinational firms...

  • What Hath GSK Wrought? More Compliance Lessons From China

    In an article, entitled “GSK China probe flags up wider worries”, in the Wednesday edition of the Financial Times (FT) reporters Andrew Jack and Patti Waldmeir discussed the ongoing bribery and corruption scandal involving the UK based pharmaceutical company, GlaxoSmithKline PLC (GSK). They detailed many of the allegations which had been previously made public against GSK, the effect of these...

  • Letter From China-Interview With Amy Sommers

    Ed. Note-this article is one of a continuing series of interviews of thought leaders in FCPA, Bribery Act and anti-corruption/anti-bribery. In this blog post, I interview Amy Sommers, partner in the Shanghai office of K&L Gates, an international law firm. 1. Where did you go to university and what experiences there led to your current profession? For both undergraduate and law...

  • And The Hits Just Keep On Coming For The ‘Sons And Daughters’ Hiring Program

    About the best thing that you can say for the Houston Texans is that they did not lose on Sunday. Of course they did not play on Sunday, pathetically losing Week 14’s game last Thursday.

  • Does Motive Matter In Anti-Bribery And Anti-Corruption Enforcement?

    Do the intentions behind enforcement of domestic or international anti-corruption laws matter? Or is ‘the law the law’ and it really does not matter what a government’s motives are in enforcing laws that it has on the books.

  • Where Else? JP Morgan Chase Investigation Into Hiring Practices Expands

    One of the most dreaded questions in any Foreign Corrupt Practices Act (FCPA) investigation is: Where Else? By this I mean that if you have a systemic failure of internal controls in one geographic area it may well be that there are other failures in other areas.

  • FCPA Charges Relating To Gift-Giving In China

    Ed. Note-today’s post is a chart prepared by Amy Sommers and Matt Morley, partners at K&L Gates. I found it to be a great resource to show FCPA enforcement actions involving gift-giving in China.

  • Welcome Back My Friends To The Show That Never Ends

    ...“Welcome back my friends” would certainly seem to be an excellent way to introduce today’s topic; that being the stunning report in the Sunday New York Times (NYT), that JP Morgan is under Foreign Corrupt Practices Act (FCPA) scrutiny in China for its hiring practices.

  • Where’s The Ball? Lesson For The Compliance Practitioner In China

    Where’s the ball? That iconic question was asked by Oakland A’s center fielder Chris Young to Houston Astro left fielder Robbie Grossman near second base late Wednesday night, as Grossman was returning to the dugout after robbing Young of a game-winning walk-off home run by literally catching Young’s shot after it was over the left field fence.

  • GSK And Missed Red Flags In China

    One of the questions that GlaxoSmithKline PLC (GSK) will have to face during the next few years of bribery and corruption investigations is how an allegedly massive bribery and corruption scheme occur in its Chinese operations?

  • The Films Of Satyajit Ray And The GSK China Investigation: Both Game-Changers

    If you are in London this week, I might suggest that you drop by the British Film Institute (BFI), which is celebrating the work of the Indian film maker, Satyajit Ray.

  • Board Of Directors And Doing Business In China Under The FCPA

    The case of GlaxoSmithKline PLC (GSK) is still resonating across the corporate globe.

  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT